Curran Terrie 4
4 · Arcutis Biotherapeutics, Inc. · Filed Nov 13, 2024
Insider Transaction Report
Form 4
Curran Terrie
Director
Transactions
- Sale
Common Stock
2024-11-11$10.85/sh−8,687$94,238→ 10,139 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.7542 to $10.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.